Difference between revisions of "Collagen (TG2)"
(New page: {{subst:infobox}}) |
|||
Line 1: | Line 1: | ||
− | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
Line 12: | Line 11: | ||
|- | |- | ||
| Determination type | | Determination type | ||
− | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
Line 18: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
− | | | + | | Cytosol/Extracellular |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
− | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P02461 P02461 ] |
+ | [http://au.expasy.org/uniprot/P020908 P020908 ] | ||
+ | [http://au.expasy.org/uniprot/Q02388 Q02388 ] | ||
+ | [http://au.expasy.org/uniprot/P12107 P12107 ] | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
− | | | + | | III.-Q14 |
+ | |||
+ | proVII.-Q2796, Q2800, Q2805, Q2807* | ||
+ | |||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
Line 30: | Line 35: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | | + | | III.-CSHLG''Q''SYADR |
+ | |||
+ | VII.-RGFVR''Q''EMS''Q''HCAC''Q''G''Q''FIASG* | ||
+ | |||
|- | |- | ||
| Structure | | Structure | ||
− | | | + | | No available crystal structure |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
− | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Line 42: | Line 50: | ||
|- | |- | ||
| Reference | | Reference | ||
− | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=2879837&dopt=Abstract PMID:2879837] |
+ | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=8787681&dopt=Abstract PMID:8787681] | ||
+ | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7577969&dopt=Abstract PMID:7577969] | ||
|- | |- | ||
| Notes | | Notes | ||
− | | | + | | * These residues are potential TG2 glutamine donor substrates situated on NC-2 domain of procollagen VII. |
+ | |||
+ | The crosslink catalyzed by transglutaminases are important for the protein's physiological functions | ||
+ | |||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | |
Revision as of 09:56, 23 July 2007
Template:Infobox header| Collagen (TG2) | |
---|---|
Collagen (TG2) | |
Substrate peptide name | Collagen (TG2) |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Cytosol/Extracellular |
Swissprot ID | P02461 |
Reactive glutamines | III.-Q14
proVII.-Q2796, Q2800, Q2805, Q2807* |
Reactive lysines | Not determined yet |
Substrate sequence | III.-CSHLGQSYADR
VII.-RGFVRQEMSQHCACQGQFIASG* |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:2879837 |
Notes | * These residues are potential TG2 glutamine donor substrates situated on NC-2 domain of procollagen VII.
The crosslink catalyzed by transglutaminases are important for the protein's physiological functions |
Template:Infobox header | |